Header cover image

Investing Ideas
/
U.S. Pharmaceuticals & Biotech Huge Earnings Growth

U.S. Pharmaceuticals & Biotech Huge Earnings Growth

Results

31

0 new

Companies which grew earnings more than 50% in the last year.

31 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	GBLX GB Sciences	US$0.0055	-15.4%	-53.2%	US$2.6m	n/a	PE-1.4x	n/a	n/a
	ATAI Atai Life Sciences	US$1.16	-3.3%	-6.5%	US$196.3m	US$9.25	PS514.9x	E35.4%	n/a
	PRQR ProQR Therapeutics	US$1.82	8.3%	45.6%	US$149.5m	US$4.13	PS8.5x	E-4.6%	n/a
	ORTX Orchard Therapeutics	US$16.70	0.9%	188.9%	US$380.1m	US$16.00	PS17.4x	E12.5%	n/a
	AKBA Akebia Therapeutics	US$1.32	0.8%	14.8%	US$279.7m	US$5.50	PS1.6x	E67.1%	n/a
	WINT Windtree Therapeutics	US$2.39	-30.3%	-87.0%	US$1.5m	US$7.00	PB0.4x	E-84.7%	n/a
	SCNI Scinai Immunotherapeutics	US$3.45	1.2%	-59.4%	US$3.1m	n/a	PS10.2x	n/a	n/a

Page 2 of 2